PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084789
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084789
Photoplethysmography Biosensors Market is estimated to be valued at USD 900 Mn in 2026 and is expected to reach USD 2,400 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 900 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 16.90% | 2033 Value Projection: | USD 2,400 Mn |
Photoplethysmography (PPG) is an optical technique used for detecting volumetric changes in blood in peripheral circulation. It is a low-cost, non-invasive method used on the skin's surface for taking measurements.
PPG technology is used in a variety of commercially available medical devices to measure oxygen saturation, blood pressure, and cardiac output, as well as to assess autonomic function and detect peripheral vascular disease.
Wearable pulse rate monitors have been developed using PPG technology. These low-cost, small devices use high-intensity green light-emitting diodes (LEDs) and photo detectors to provide non-invasive pulse rate monitoring. Miniaturization, robustness, and user-friendliness are critical design requirements for these systems.
Market players are focused on new product launches and approvals, which could contribute to the growth of the global photoplethysmography (PPG) biosensors market over the forecast period. For instance, on September 28, 2020, Masimo, a global medical technology company, announced that the Rad-G Pulse Oximeter has received U.S. Food and Drugs Administration (FDA) clearance. This rugged handheld device provides clinically proven SET pulse oximetry, respiration rate, and other vital parameters for both spot-checking and continuous monitoring. Rad-G offers the ultimate handheld versatility, and can be used in a variety of settings including but not limited to physicians' offices, outpatient services, long-term care facilities, wellness clinics, first-response scenarios, and limited-resource environments.
Market players are focusing on product launches, which is expected to strengthen their position in the global photoplethysmography (PPG) biosensors market. For instance, on April 07, 2021, MFine, a Bengaluru-based health-tech startup, unveiled 'MFine Pulse,' an app-based SPO2 monitoring tool that can help people to keep track of their oxygen saturation levels using their smartphones. MFine has developed a proprietary algorithm that uses a smartphone camera to measure oxygen saturation. The smartphone camera is used to obtain a photoplethysmogram (PPG) signal from the user's fingertip. The PPG is an optically obtained plethysmogram that can be used to detect changes in blood volume in the tissue's microvascular bed. The LED illuminates the skin, while the smartphone camera detects changes in light absorption.
Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the global photoplethysmography (PPG) biosensors market. For instance, on November 29, 2018, Huami Corporation, a biometric and activity data-driven company with significant expertise in smart wearable technology, partnered with Timex Group, a global leader in watchmaking. According to the agreement, the companies will investigate opportunities to develop new products and expand their global presence in the smart wearables market, combining Timex's longstanding expertise as watchmakers with Huami's cutting-edge artificial intelligence technology, app design, and manufacturing capabilities, to create a new generation of smart watches that deliver on performance, style, and functionality.